AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Sheftell, FD Fox, AW Weeks, RE Tepper, SJ
Citation: Fd. Sheftell et al., Differentiating the efficacy of 5-HT1B/1D agonists, HEADACHE, 41(3), 2001, pp. 257-263

Authors: Sheftell, FD Fox, AW
Citation: Fd. Sheftell et Aw. Fox, Acute migraine treatment outcome measures: a clinician's view, CEPHALALGIA, 20, 2000, pp. 14-24

Authors: Sheftell, FD Rapoport, AM Coddon, DR
Citation: Fd. Sheftell et al., Worsening of transformed migraine with naratriptan as prophylactic treatment - Reply, HEADACHE, 40(7), 2000, pp. 611-611

Authors: Sheftell, FD Rapoport, AM Coddon, DR
Citation: Fd. Sheftell et al., Naratriptan prophylaxis of transformed migraine or hemicrania continua? Reply from Sheftell et al., HEADACHE, 40(6), 2000, pp. 499-499

Authors: Sheftell, FD Rapoport, AM Coddon, DR
Citation: Fd. Sheftell et al., Reply to Warner re: "Naratriptan in the prophylaxis of transformed migraine" (Headache, 1999;39 : 506-510), HEADACHE, 40(3), 2000, pp. 252-252

Authors: Dahlof, CGH Rapoport, AM Sheftell, FD Lines, CR
Citation: Cgh. Dahlof et al., Rizatriptan in the treatment of migraine, CLIN THER, 21(11), 1999, pp. 1823-1836

Authors: Sheftell, FD Rapoport, AM Coddon, DR
Citation: Fd. Sheftell et al., Naratriptan in the prophylaxis of transformed migraine, HEADACHE, 39(7), 1999, pp. 506-510
Risultati: 1-7 |